MicroPort NeuroTech Limited (HK:2172) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
MicroPort NeuroTech Limited reported a significant 36.4% revenue increase in the first half of 2024, driven by successful overseas expansion, growing market share of intracranial atherosclerotic stenosis products, and strong sales of coil products and new stroke and access products. The company’s revenue surge was particularly marked by an 87% jump in international sales compared to the prior year. Additionally, MicroPort NeuroTech has announced its plans to distribute an interim dividend of HK$0.08 per share to its shareholders.
For further insights into HK:2172 stock, check out TipRanks’ Stock Analysis page.